FDA Warning Letter — Palace Drugs

Case 679371 — FEI 3030549953

The FDA took a Warning Letter action against Palace Drugs on Mar 7, 2024 (Jersey City, NJ). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Palace Drugs
Date
Mar 7, 2024
Fiscal Year
2024
Product Type
Tobacco
Center
CTP
Location
Jersey City, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.